Non-Muscle Invasive Bladder Cancer: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 119: | Line 119: | ||
*# '''<span style="color:#ff0000">Intermediate-risk (suspected or known) NMIBC</span>''' | *# '''<span style="color:#ff0000">Intermediate-risk (suspected or known) NMIBC</span>''' | ||
==== 2021 CUA ==== | ====== 2021 CUA ====== | ||
* '''<span style="color:#ff0000">Recommended (2):</span>''' | * '''<span style="color:#ff0000">Recommended (2):</span>''' | ||
*# '''<span style="color:#ff0000">Intermediate-risk NMIBC</span>''' | *# '''<span style="color:#ff0000">Intermediate-risk NMIBC</span>''' | ||
| Line 127: | Line 126: | ||
** '''<span style="color:#ff0000">All patients with presumed low-risk NMIBC at TURBT</span>''' | ** '''<span style="color:#ff0000">All patients with presumed low-risk NMIBC at TURBT</span>''' | ||
===== Contraindications ===== | |||
# '''<span style="color:#ff0000">After extensive resection''' | # '''<span style="color:#ff0000">After extensive resection''' | ||
# '''<span style="color:#ff0000">Suspected bladder perforation''' | # '''<span style="color:#ff0000">Suspected bladder perforation''' | ||